-
January 30, 2013
Anacor Pharmaceuticals, Inc. (ANAC) recently announced positive preliminary results on tavaborole (AN2690) from ...
-
January 30, 2013
Santarus, Inc. (SNTS) recently filed a patent infringement lawsuit against Mylan, Inc. (MYL) which is looking to ...
-
January 30, 2013
ARIAD Pharmaceuticals, Inc. (ARIA) recently announced the closure of its previously announced public offering. ARIAD ...
-
January 29, 2013
In a bid to establish its presence in the highly sought after Indian market, US based Endo Health Solutions Inc. ...
-
January 29, 2013
Spectrum Pharmaceuticals (SPPI) recently announced safety findings from the phase II BELIEF study on belinostat. ...
-
January 29, 2013
Sanofi's (SNY) subsidiary, Genzyme, recently announced that the US Food and Drug Administration (FDA) has accepted ...
-
January 28, 2013
ImmunoGen Inc. (IMGN) reported second quarter fiscal 2013 adjusted loss of 29 cents per share, wider than both the ...
-
January 25, 2013
Gilead Sciences Inc. (GILD) recently initiated the first of two phase III studies on tenofovir alafenamide (TAF). ...
-
January 25, 2013
Celgene Corporation (CELG) recently announced that its oncology drug, Abraxane, has performed well in a phase III ...
-
January 24, 2013
Celgene Corporation's (CELG) fourth quarter 2012 earnings (excluding special items but including stock-based ...
-
January 24, 2013
Cubist Pharmaceuticals Inc.'s (CBST) fourth quarter 2012 earnings (excluding special items) of 48 cents per share ...
-
January 23, 2013
Novo Nordisk (NVO) recently announced that it has received approval in the EU (covering all 27 states) for its ...
-
January 23, 2013
Novartis' (NVS) global eye care division, Alcon, recently received a positive opinion from the Committee for ...
-
January 23, 2013
Impax Laboratories, Inc. (IPXL) received a major setback recently with the US Food and Drug Administration (FDA) ...
-
January 22, 2013
The US Patent and Trademark Office (USPTO) recently extended the patent covering Spectrum Pharmaceuticals' (SPPI) ...
-
January 22, 2013
Forest Laboratories, Inc. (FRX) recently announced the Canadian approval of its hypertension treatment, Bystolic ...
-
January 22, 2013
Questcor Pharmaceuticals Inc. (QCOR) recently announced that it has completed the acquisition of BioVectera Inc. ...
-
January 18, 2013
ViroPharma (VPHM) recently announced that The Journal of Pediatrics published data in an article on Jan 14, 2013, ...
-
January 18, 2013
Exelixis, Inc. (EXEL) recently announced that it has received a notice from its partner, Roche Holding (RHHBY), ...
-
January 18, 2013
NuPathe, Inc. (PATH) announced that the US Food and Drug Administration (FDA) has approved Zecuity (sumatriptan ...
